Using depression and suicide screenings and other resources can help save lives
Sep. 2024Important Notices
Caring for your patients’ mental health needs is essential to their overall well-being. You can use these and other processes and resources to support their behavioral health needs.
- Implement the National Institute of Mental Health action steps for helping someone in emotional pain:
- Ask: Are you thinking about harming yourself?
- Keep them safe: Reduce access to lethal items or places. Be there: Listen carefully and acknowledge their feelings.
- Help them connect: Call or text the 988 Suicide and Crisis Lifeline at 988.
- Stay connected: Stay in touch after a crisis.
- Take free continuing medical education (CME) courses centered around suicide and depression to help you increase the depth and quality of care you provide: These activities are approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in these activities.
- Know about other tools that can help you provide appropriate support:
- Crisis hotlines, such as Trevor Lifeline 24/7 crisis support for LGBTQIA+ youth and Trans Lifeline24/7 crisis and peer support
- Behavioral health resources, such as:
- National Institute of Mental Health
- Zero Suicide: Screen/Assess
- American Foundation for Suicide Prevention
- American Academy of Pediatrics
- Columbia Suicide Severity Rating Scale (C-SSRS)
- Ask Suicide-Screen Questions (ASQ) for ages 10-24
- Suicide Assessment Five-Step Evaluation and Triage (SAFE-T)
- Telephonic Psychiatric Consultation Service Program for PA Medical Assistance
Recent Announcements
Medicaid Renewal
Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.Aug. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Aug. 2026Important Notices
Voluntary nationwide recall: Tyenne (Fresenius – August 2026)
Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.Aug. 2026Pharmacy Updates